Patents by Inventor Roger K. Maes

Roger K. Maes has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Compositions for the diagnosis and treatment of epizootic catarrhal enteritis in ferrets
    Patent number: 7255986
    Abstract: The present invention relates to the use of novel nucleotide sequences for the M and N region peptide of the ferret coronavirus and derivative products for the diagnosis and treatment of epizootic catarrhal enteritis (ECE) in ferrets.
    Type: Grant
    Filed: January 30, 2003
    Date of Patent: August 14, 2007
    Assignee: The Board of Trustees Operating Michigan State University
    Inventors: Roger K. Maes, Annabel G. Wise, Matti Kiupel
  • Multiplex RT-PCR/PCR for simultaneous detection of bovine coronavirus, bovine rotavirus, Cryptosporidium parvum, and Escherichia coli
    Patent number: 6867021
    Abstract: The present invention provides a multiplex RT-PCR/PCR method, which enables in a single assay the simultaneous detection of any combination of bovine rotavirus, bovine coronavirus, Cryptosporidium parvum, and optionally, Escherichia coli strains producing K99 pili or heat-stable enterotoxin STa.
    Type: Grant
    Filed: February 20, 2001
    Date of Patent: March 15, 2005
    Assignee: Board of Trustees of Michigan State University
    Inventors: Roger K. Maes, Annabel G. Wise
  • Epizootic catarrhal enteritis prevention, treatment and diagnosis
    Publication number: 20040038202
    Abstract: The present invention relates to the use of novel nucleotide sequences for the spike peptide, pol region peptide and M and N region peptide of the ferret coronavirus and derivative products for the diagnosis and treatment of epizootic catarrhal enteritis (ECE) in ferrets.
    Type: Application
    Filed: January 30, 2003
    Publication date: February 26, 2004
    Applicant: Michigan State University
    Inventors: Roger K. Maes, Annabel G. Wise, Matti Kiupel
  • Feline calicivirus isolated from cat urine and vaccines thereof
    Patent number: 6355246
    Abstract: The present invention provides an isolated feline calicivirus and mutants thereof, which were isolated from the urine of a cat with lower urinary tract disorder. The present invention further provides nucleic acid clones of the virus, in particular, a clone which encodes the capsid antigen of the virus. The present invention is useful for providing a live or killed virus vaccine comprising the virus or mutants thereof, a subunit vaccine comprising the capsid antigen of the virus, a nucleic acid vaccine encoding the capsid antigen of the virus, and a recombinant virus vector vaccine encoding the capsid antigen of the virus. The present invention also provides a method for isolating feline calicivirus from urine and an assay for diagnosing cats infected with feline calicivirus.
    Type: Grant
    Filed: June 8, 2000
    Date of Patent: March 12, 2002
    Assignee: Board of Trustees of Michigan State University
    Inventors: John M. Kruger, Roger K. Maes, Aivars Vilnis
  • Recombinant poxvirus vaccine against feline rhinotracheitis
    Patent number: 6010703
    Abstract: A recombinant poxvirus vaccine against feline herpesvirus (FHV-1) is described. The recombinant poxviruses include synthetic genes encoding either a gB or gD precursor polypeptide or mixtures of the two recombinant poxviruses. The vaccine is used to provide immunity to FHV-1 in cats.
    Type: Grant
    Filed: August 14, 1997
    Date of Patent: January 4, 2000
    Assignee: Board of Trustees operating Michigan State University
    Inventors: Roger K. Maes, Stephen J. Spatz